DOSE Asve Pharmaceutical
The stored series is adjusted. Raw is the price the exchange quoted that day.
- High
- 97,050
- Low
- 22,234
- Period change
- up297.81%
Board events
- Buy queue: 995,422 shares bid at 97,050 Rial.
- Reached its highest level in a year: 94,230 Rial.
- 4 consecutive higher closes.
Trading board
- Last trade
97,050Rial
- up2.99%
- Bid queue
- Closing price
97,050Rial
- up2.99%
- Yesterday's close
94,230Rial
- Daily price band
- 91,410–97,050
- Market cap
72.8trillion Rial
- Earnings per share (EPS)
- 6,427
- Price/earnings (P/E)
- 15.10
- Shares outstanding
750million
- Trades
- 33
- Volume
66,822
- Turnover
6.5billion Rial
- Retail · Buy
66,822
- Retail · Sell
66,822
- Institutional · Buy
0
- Institutional · Sell
0
- Net retail
- 0
- Buyer-to-seller strength
- 7.25
Fundamentals
- EPS (trailing twelve months)
6,427Rial
- Price to earnings (P/E)
- 15.10
- Sector P/E
- 12.20
- Price to sales (P/S)
- 3.08
- Sales per share
31,484Rial
- Free float
- 9.00%
- Average monthly volume
1.2million
- Sector
- مواد و محصولات دارویی
- Market
- بازار بورس
- Board
- بازار دوم (تابلوی فرعی) بورس
- Updated
- Sep 4, 2026
Major shareholders
Holdings as counted for the assembly of Mar 10, 2025. The named holders together held 90.91% of the shares.
Shareholder register
The Tehran exchange register, as of Aug 26, 2026. The named holders together hold 90.78% of the shares.
Source: the Tehran exchange's daily shareholder register. The exchange names only holders at roughly one percent and above, so this is a floor on known ownership: the rest is spread across smaller holders it does not name.
Retail flow history
| Date | Net retail |
|---|---|
| Aug 8, 2026 | 210,000 |
| Aug 9, 2026 | -1,427,944 |
| Aug 10, 2026 | 60,000 |
| Aug 11, 2026 | 90,000 |
| Aug 15, 2026 | 86,894 |
| Aug 16, 2026 | 78,877 |
| Aug 17, 2026 | 400,000 |
| Aug 18, 2026 | 150,000 |
| Aug 25, 2026 | -1,149,815 |
| Aug 29, 2026 | 1,105,000 |
| Aug 31, 2026 | 243,236 |
| Sep 1, 2026 | -277,822 |
| Sep 2, 2026 | 70,955 |
| Sep 5, 2026 | 0 |
- Retail buy per capita
1,621,268,775Rial
- Retail sell per capita
223,623,279Rial
Values in this window are estimated: volume times the same day closing price.
Price statistics
52-week range
- Today's rank in its market
- 48 of 721
- From 52-week high
- unchanged0.00%
- 20-day volatility
- 1.93%
- 20-day average
85,556Rial
- 50-day average
64,648Rial
- 30-day average volume
- 1.4million
- Correlation with the dollar (30d)
- -0.08
- Correlation with the dollar (90d)
- 0.02
As of Sep 5, 2026
All-time high and low
- All-time high
97,050Rial
Sep 5, 2026- All-time low
829.17Rial
Apr 7, 2001- From the all-time high
- unchanged0.00%
- Deepest fall (5 years)
- down59.17%May 6, 2023 to Oct 11, 2025
Returns
Same group
Recent records
Symbol timeline
Supervisor messageHalt of the (DOSE1) symbol due to a price increase of more than 50 percent
Esteemed market participants are informed that the trading symbol of Osveh Pharmaceutical Company (DOSE1), given the increase of more than 50 percent in the share price, has been halted in order for the issuer to hold an information conference. Therefore, esteemed participants who have access to the Tedan system are requested, should they have any ambiguity or question, to register their views on the aforementioned website at tedan.ir by the end of the current day at the latest, for review and response by the issuer. Tehran Stock Exchange Share Market Operations Management
Extraordinary General Meeting — DOSE
Supervisor messageReopening of the trading symbol (DOSE)
It is hereby announced that the trading symbol of Osveh Pharmaceutical Company (DOSE), following the holding of the extraordinary general meeting (annual general meeting held extraordinarily), is ready for trading with a price fluctuation limit. Market Operations Management of Tehran Stock Exchange
Supervisor messageHalt of trading symbols (ASIA), (SDAB), (SRMA), (SINA), (DOSE), (Kchadh)
This is to inform that, at the end of today's trading, the trading symbols of Asia Insurance (ASIA), Darab Cement (SDAB) — for holding annual ordinary general meetings for the approval of financial statements, and an extraordinary general meeting for deciding on a capital increase — Sarma Afarin Iran Industries (SRMA), Sina Tile and Ceramic Industries (SINA) — for holding annual ordinary general meetings for the approval of financial statements, and an extraordinary general meeting for amending the articles of association — Osveh Pharmaceutical (DOSE) — for holding an extraordinary ordinary general meeting — and the pre-emption right of Chadormalu Mining and Industrial Company (Kchadh), given the expiry of the deadline for exercising the pre-emption right to purchase shares, will be halted. Tehran Stock Exchange Market Operations Management